The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
MICROBIAL PERSISTENCE
Open accessAbstract
A previously reported form of microbial persistence whereby large populations of tubercle bacilli can be made to "vanish" uniformly from the tissues of mice has been shown to occur generally throughout each group of animals subjected to the experimental procedure; it does not reflect the eradication of the bacilli in the majority of animals with their persistence and ultimate revival in only a minority. The one demonstrable alteration of the tubercle bacilli while "vanished" is that they are sterile. Thus, they are undetectable by cell-free culture, tissue culture, and blind animal passage, i.e. by any method based on microbial multiplication. Whether they have also undergone alteration in morphology and persist in some unconventional form cannot be stated. Acid-fast forms similar to tubercle bacilli can be detected in small numbers by intensified microscopic search of tissue homogenates but the relationship of these forms to the sterile bacilli that ultimately revive is unclear. Thus, the persisting tubercle bacilli are more correctly designated as being in a "sterile state" than one of true latency. The uniform induction of the sterile state is a specific phenomenon requiring the participation of both the nicotinamide derivative, pyrazinamide, and isoniazid. Once assumed, this sterile state is relatively stable and the time required for revival of the tubercle bacilli in the spleens in one-half the animals is seven months. This process can be speeded up by the administration of large doses of cortisone in the third or fourth month after sterilization but revival is not significantly affected by the administration of cortisone earlier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrition Needs of Mammalian Cells in Tissue Culture
Eagle, H. (1955) · Science · doi:10.1126/science.122.3168.501 · Cited by 1,619
McCune, R. M., Tompsett, R., & McDermott, W. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.104.5.763 · Cited by 307
Self-citationMcCune, R. M., & Tompsett, R. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.104.5.737 · Cited by 260
Self-citationMcCune, R. M., Feldmann, F. M., & McDermott, W. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.3.469 · Cited by 157
Self-citationMcDERMOTT, W. (1958) · PubMed Central · Cited by 152
Self-citationRees, R. J. W., & Hart, P. D. (1961) · PubMed · Cited by 99
McDermott, W. (1959) · Public Health Reports (1896-1970) · doi:10.2307/4590490 · Cited by 50
Self-citationBatten, J. C., & McCune, R. M. (1957) · PubMed · Cited by 20
Self-citation
Cited by
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Mycobacterium tuberculosis: success through dormancy
Gengenbacher, M., & Kaufmann, S. H. E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00331.x · Cited by 696
Kell, D. B., Kaprelyants, A. S., Weichart, D. H., Harwood, C. R., & Barer, M. R. (1998) · Antonie van Leeuwenhoek · doi:10.1023/a:1000664013047 · Cited by 581
Persistent bacterial infections: the interface of the pathogen and the host immune system
Monack, D. M., Mueller, A., & Falkow, S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro955 · Cited by 572
M. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., Wang, H., Zhang, W., & Zhang, Y. (2011) · Science · doi:10.1126/science.1208813 · Cited by 514
Tuberculosis: Latency and Reactivation
Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4195-4201.2001 · Cited by 500
Mechanisms of latency in Mycobacterium tuberculosis
Parrish, N. M., Dick, J. D., & Bishai, W. R. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01216-5 · Cited by 483
Therapy of tuberculosis in mice by DNA vaccination
Lowrie, D. B., Tascon, R. E., Bonato, V. L. D., Lima, V. M. F., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinson, R. G., Moelling, K., & Silva, C. L. (1999) · Nature · doi:10.1038/22326 · Cited by 474
Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
Aldridge, B. B., Fernandez-Suarez, M., Heller, D., Ambravaneswaran, V., Irimia, D., Toner, M., & Fortune, S. M. (2012) · Science · doi:10.1126/science.1216166 · Cited by 454
Molecular Epidemiology of Tuberculosis: Current Insights
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-05 · Cited by 413
The Secret Lives of the Pathogenic Mycobacteria
Cosma, C. L., Sherman, D. R., & Ramakrishnan, L. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.091033 · Cited by 407
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Tufariello, J. M., Chan, J., & Flynn, J. L. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00741-2 · Cited by 403
Tuberculosis: a problem with persistence
Stewart, G. R., Robertson, B. D., & Young, D. B. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro749 · Cited by 386
Formation, physiology, ecology, evolution and clinical importance of bacterial persisters
Van den Bergh, B., Fauvart, M., & Michiels, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux001 · Cited by 381
Mechanisms of Pyrazinamide Action and Resistance
Zhang, Y., Shi, W., Zhang, W., & Mitchison, D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0023-2013 · Cited by 332
Yuan, Y., Crane, D. D., Simpson, R. M., Zhu, Y., Hickey, M. J., Sherman, D. R., & Barry, C. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9578 · Cited by 314
Basic Mechanisms of Chemotherapy
Mitchison, D. A. (1979) · Chest · doi:10.1378/chest.76.6.771 · Cited by 301
A family of autocrine growth factors in Mycobacterium tuberculosis
Mukamolova, G. V., Turapov, O. A., Young, D. I., Kaprelyants, A. S., Kell, D. B., & Young, M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03184.x · Cited by 291
Deb, C., Daniel, J., Sirakova, T. D., Abomoelak, B., Dubey, V. S., & Kolattukudy, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505556200 · Cited by 276
Latent Mycobacterium tuberculosis–persistence, patience and winning by waiting
Manabe, Y. C., & Bishai, W. R. (2000) · Nature Medicine · doi:10.1038/82139 · Cited by 275
Targeting Persisters for Tuberculosis Control
Zhang, Y., Yew, W. W., & Barer, M. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06288-11 · Cited by 271
Radaeva, T. V., Nikonenko, B. V., Mischenko, V. V., Averbakh, M. M., & Apt, A. S. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.09.014 · Cited by 36
Kumar, N., Sharma, S., & Kaushal, P. S. (2024) · Nature Communications · doi:10.1038/s41467-024-44879-y · Cited by 20
Are all antibiotic persisters created equal?
Shultis, M. W., Mulholland, C. V., & Berney, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.933458 · Cited by 19
Metadata
- Authors
- McCune, R. M., Feldmann, F. M., Lambert, H. P., & McDermott, W.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1966-03-01
- Volume
- 123
- Issue
- 3
- Pages
- 445-468
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2152352130
- Cited by
- 310
- References
- 8
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.